Generation of Biological Samples Positive to Hydromorphone for Anti-doping Control

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

December 18, 2019

Study Completion Date

December 18, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

Hydromorphone Hydrochloride

4 mg of hydromorphone hydrochloride (equivalent to 3.56 mg of hydromorphone) administered orally in a single dose.

Trial Locations (1)

IMIM (Hospital del Mar Medical Research Institute), Barcelona

All Listed Sponsors

lead

Parc de Salut Mar

OTHER

NCT04081376 - Generation of Biological Samples Positive to Hydromorphone for Anti-doping Control | Biotech Hunter | Biotech Hunter